Deep Medicine Acquisition Stock Z Score
| DMAQDelisted Stock | USD 11.59 0.12 1.02% |
Deep |
Deep Medicine Acquisition Company Z Score Analysis
Deep Medicine's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Deep Medicine Z Score | 2.74 |
Most of Deep Medicine's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Deep Medicine Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionAccording to the company's disclosures, Deep Medicine Acquisition has a Z Score of 2.74. This is 13.69% higher than that of the Capital Markets sector and significantly higher than that of the Financials industry. The z score for all United States stocks is 68.58% higher than that of the company.
Deep Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Deep Medicine's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Deep Medicine could also be used in its relative valuation, which is a method of valuing Deep Medicine by comparing valuation metrics of similar companies.Deep Medicine is currently under evaluation in z score category among its peers.
Deep Fundamentals
| Return On Asset | -0.0176 | |||
| Current Valuation | 15.74 M | |||
| Shares Outstanding | 4.36 M | |||
| Shares Owned By Insiders | 74.08 % | |||
| Shares Owned By Institutions | 28.73 % | |||
| Number Of Shares Shorted | 10.3 K | |||
| Price To Book | 22.01 X | |||
| EBITDA | (3.99 M) | |||
| Net Income | (400.23 K) | |||
| Cash And Equivalents | 707.98 K | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 1.86 M | |||
| Current Ratio | 229.55 X | |||
| Book Value Per Share | (1.69) X | |||
| Cash Flow From Operations | (1.04 M) | |||
| Short Ratio | 0.33 X | |||
| Earnings Per Share | (0.13) X | |||
| Beta | 0.017 | |||
| Market Capitalization | 12.9 M | |||
| Total Asset | 9.78 M | |||
| Retained Earnings | (6.44 M) | |||
| Working Capital | 6.98 M | |||
| Z Score | 2.74 | |||
| Net Asset | 9.78 M |
About Deep Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Deep Medicine Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Deep Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Deep Medicine Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Deep Medicine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Deep Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Deep Medicine will appreciate offsetting losses from the drop in the long position's value.Moving against Deep Stock
| 0.82 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.79 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.78 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.74 | BKRKY | Bank Rakyat | PairCorr |
| 0.74 | PTBRY | Bank Negara Indonesia Normal Trading | PairCorr |
The ability to find closely correlated positions to Deep Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Deep Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Deep Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Deep Medicine Acquisition to buy it.
The correlation of Deep Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Deep Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Deep Medicine Acquisition moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Deep Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Deep Stock
If you are still planning to invest in Deep Medicine Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deep Medicine's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |